ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

MYL Mylan NV

15.855
0.00 (0.00%)
After Hours
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Mylan NV NASDAQ:MYL NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 15.855 15.71 15.90 0 01:00:00

Mylan Schedules Fourth Quarter and Year End 2014 Financial Results Conference Call and Live Webcast

09/02/2015 4:45pm

PR Newswire (US)


Mylan NV (NASDAQ:MYL)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Mylan NV Charts.

PITTSBURGH, Feb. 9, 2015 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) announced today that it will host a conference call and live webcast, including a slide presentation, on Monday, March 2, 2015, at 4:30 p.m. ET, to review the company's financial results for the fourth quarter and year ended Dec. 31, 2014. The company also will be providing its financial guidance for 2015.  Mylan will release its financial results on March 2 after the market closes.

Mylan

The dial-in number to access the call is 800.514.4861 or 678.809.2405 for international callers. A replay, available for approximately seven days, will be available at 855.859.2056 or 404.537.3406 for international callers; passcode 80024983.

To access the live webcast, please log on to Mylan's Web site (www.mylan.com) at least 15 minutes before the event is to begin to register and download or install any necessary software. A replay of the webcast will be available on www.mylan.com for a limited time.

About Mylan

Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 1,300 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately 40% of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in approximately 140 countries and territories. Our workforce of more than 25,000 people is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around the world. Learn more at mylan.com. 

Logo - http://photos.prnewswire.com/prnh/20140423/77793

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mylan-schedules-fourth-quarter-and-year-end-2014-financial-results-conference-call-and-live-webcast-300032866.html

SOURCE Mylan Inc.

Copyright 2015 PR Newswire

1 Year Mylan NV Chart

1 Year Mylan NV Chart

1 Month Mylan NV Chart

1 Month Mylan NV Chart

Your Recent History

Delayed Upgrade Clock